Chris Ryan is the Managing Editor at OncLive. With a background in sports journalism, he has transitioned into covering critical themes in medicine and healthcare, including oncology, immunotherapy, and mental health care. He has been featured in various prominent publications such as NJ Cannabis Insider, New York Daily News, and Scientific American.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Australia (National)
Not enough data
Chris Ryan covers a diverse range of topics, including sports events, entertainment news, and healthcare. He often cites data and press releases in his articles.
For the sports-related content he covers, Chris may be interested in receiving information on upcoming basketball games or championships, particularly those with compelling storylines or underdog victories. Additionally, for healthcare topics like prostate cancer care and mask mandates, he might appreciate pitches that provide new data insights or unique perspectives from experts in these fields. When it comes to entertainment news such as TV episodes and movie reviews, he might be open to exclusive interviews with directors or actors involved in highly-anticipated productions.
Given Chris's varied coverage without a specific geographic focus mentioned, PR professionals can tailor their pitches according to the themes covered by him rather than focusing on a particular location.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Chris Ryan
Experts break down key multiple myeloma data and trends from the 23rd Annual IMS Meeting.
By: Chris Ryan
The FDA approved tucatinib plus trastuzumab and pertuzumab as maintenance for advanced HER2-positive breast cancer after induction.
The FDA approved atezolizumab plus chemotherapy for the adjuvant treatment of stage III mismatch repair–deficient colon cancer.
By: Chris Ryan
With the 2026 ESMO Congress (ESMO 2026) set to kick off on October 23 in Madrid, Spain, attention turns to the gastrointestinal (GI) cancer field, where
(PUEBLO) — CSU Pueblo quarterback Navi Bruzon has focused on doing his very best in both academics and on the football field, since childhood. Through that work ethic, Bruzon became the second ever…
By: Chris Ryan
The FDA has granted traditional approval to pembrolizumab for unresectable/metastatic TMB-H solid tumors.
I am a fourth generation Central New Yorker, born and raised in Cicero. After graduating from Cicero-North Syracuse High School and Le Moyne College, I worked as a Legislative Director in the State Senate. In that capacity, I wrote bills, analyzed policy, and advanced priorities for my member’s district.
By: Chris Ryan
The FDA approved talazoparib plus enzalutamide for HRR-positive, metastatic androgen pathway modulation–naive or -sensitive prostate cancer.
(WEST POINT, NY) — The turnaround for Air Force football rolls on. Troy Calhoun has never had three straight losing seasons as the Falcons head coach, and this season is proving why that is the case.
(WEST POINT, NY) — The turnaround for Air Force football rolls on. Troy Calhoun has never had three straight losing seasons as the Falcons head coach, and this season is proving why that is the case. Before 2026, Air Force had not won a service academy game since 2023, having lost two straight games to […]
